Chief Financial Officer,
Joel Ackerman joined the Mozarc Medical board of directors in April 2023. Joel is the Chief Financial Officer and Treasurer of DaVita, Inc., a position he’s held since 2017. He is also chairman of the board of Champions Oncology, Inc., where he previously served as chief executive officer, and is a member of the board of One Acre Fund, a not-for-profit organization that serves subsistence farmers in Africa. Previously, Joel was a managing director at Warburg Pincus, a global private equity firm. Joel previously served on the board of directors at Kindred Healthcare, Inc. and Coventry Health Care, Inc.
Senior Vice President,
Chris Cleary joined the Mozarc Medical board of directors in April 2023. He is senior vice president of Corporate Development for Medtronic, a role he has held since 2014. During this period, he has led more than 40 acquisitions, including Covidien, NGC, Twelve, Smith & Nephew, Mazor Robotics, and Epix. Chris is also responsible for Medtronic’s venture investing business, and he jointly leads Portfolio Management and Business Development for Medtronic. Prior to Medtronic, Chris worked at GE Capital, leading M&A teams that closed acquisitions and dispositions worldwide.
Chief Executive Officer,
James Corbett joined the Mozarc Medical board of directors in April 2023. James has been the chief executive officer of AVITA Medical since September 2022, after serving on AVITA’s board since June 2021. AVITA Medical is a regenerative medicine company addressing therapeutic skin restoration and is publicly traded on Nasdaq and ASX. During his 40-year career as a medical device leader, James has served as CEO of several medical device companies, including CathWorks Ltd., Microtherapeutics Inc., ev3 Inc., Alphatec Spine, Home Diagnostics, Inc., and Vertos Medical. Previously, he was general manager of Baxter Japan, and general manager and president of Scimed Life Systems, Inc., and Boston Scientific International.
Group Vice President and
Head of Corporate
Strategy, DaVita, Inc.
Scott Doniger joined the Mozarc Medical board of directors in April 2023. Scott is head of Corporate Strategy at DaVita, Inc., with oversight of enterprise strategy, new growth opportunities, partnership negotiations, and other strategic initiatives. Scott joined DaVita in 2010. Prior to DaVita, Scott was a consultant with McKinsey & Company, serving provider, pharmaceutical, and medical device clients. He began his career in scientific research with an emphasis on the genetic basis of disease.
Board Member, Senior Executive
in Life Sciences and Healthcare (Retired)
Kim Lody joined the Mozarc Medical board of directors in May 2023. She is currently a Non-Executive Director of the board for Ball Ventures, a privately held diversified investment and operating company, and Convatec Group, a medical products and technologies company. Previously, Kim was the President and CEO of Sonida Senior Living, where she led a multi-year operational and financial transformation of the company and served on the board. Over her 25+ year career, Kim has also held senior executive, Chief Marketing Officer, and Chief Operating Officer roles for such companies as GN Hearing North America, Coloplast, Senior Home Care, Gentiva Health Services, and Apria Healthcare.
Chief Executive Officer,
Ven Manda is the Chief Executive Officer of Mozarc Medical and serves on its board of directors. Before becoming CEO in 2023, he was the operating unit president of Medtronic Renal Care Solutions with a singular focus on improving the quality of life for patients with end stage renal disease through innovative medical device technology. Since joining Medtronic in 1994, Ven has served in a number of research, product development, and business leadership roles, including vice president of New Therapies and Diagnostics in Medtronic’s Cardiac Rhythm Heart Failure division, and vice president of Science, Technology, and Renal Care Solutions. Ven has previously helped introduce novel device therapies for atrial fibrillation and heart failure management.
EVP and President,
Medical Surgical Portfolio,
Bob White joined the Mozarc Medical board of directors in April 2023. He is Executive Vice President and President, Medical Surgical Portfolio, at Medtronic. Throughout his 30-plus-year career in the healthcare industry, he has served in multiple leadership positions at Medtronic, Covidien, GE Healthcare, and IBM – working at the intersection of healthcare and technology and driving strong business performance in both developed and developing markets. Bob is energized and inspired by the opportunities for Mozarc Medical to deliver transformative technology solutions and improve the lives of patients with kidney failure. He is currently a Non-Executive Director of the Smith+Nephew Board.